The role of isolated limb perfusion for melanoma confined to the extremities
- 30 April 2003
- journal article
- review article
- Published by Elsevier in Surgical Clinics of North America
- Vol. 83 (2) , 371-384
- https://doi.org/10.1016/s0039-6109(02)00095-6
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Double isolated limb infusion with cytotoxic agents for recurrent and metastatic limb melanomaEuropean Journal Of Cancer, 2001
- TNF Registered in Europe: Does TNF Get a Second Chance?Journal of Immunotherapy, 2000
- A single centre's 10 year experience with isolated limb perfusion in the treatment of recurrent malignant melanoma of the limbEuropean Journal Of Cancer, 1996
- Isolated limb perfusion with TNFα and melphalan in a rat osteosarcoma model: a new anti-tumour approachEuropean Journal of Surgical Oncology, 1996
- A retrospective comparative study evaluating the results of mild hyperthermic versus controlled normothermic perfusion for recurrent melanoma of the extremitiesEuropean Journal Of Cancer, 1995
- Regional therapy of melanomaEuropean Journal Of Cancer, 1993
- Optimization of isolated hyperthermic limb perfusionWorld Journal of Surgery, 1992
- Isolated limb perfusion for melanoma: Effectiveness and toxicity of cisplatin compared with that of melphalan and other drugsWorld Journal of Surgery, 1992
- Hyperthermic isolated perfusion with melphalan in the treatment of advanced malignant melanoma of the lower limbBritish Journal of Surgery, 1990
- Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactionsEuropean Journal of Cancer and Clinical Oncology, 1982